Wellell Inc. (TPE:4106)
Taiwan
· Delayed Price · Currency is TWD 22.65
-0.15 (-0.66%)
Mar 9, 2026, 1:30 PM CST
Wellell Revenue
Wellell had revenue of 619.09M TWD in the quarter ending September 30, 2025, with 14.23% growth. This brings the company's revenue in the last twelve months to 2.39B, down -2.38% year-over-year. In the year 2024, Wellell had annual revenue of 2.39B, down -9.84%.
Revenue (ttm)
2.39B
Revenue Growth
-2.38%
P/S Ratio
0.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.39B | -260.47M | -9.84% |
| Dec 31, 2023 | 2.65B | -16.60M | -0.62% |
| Dec 31, 2022 | 2.66B | 289.67M | 12.20% |
| Dec 31, 2021 | 2.37B | 370.03M | 18.46% |
| Dec 31, 2020 | 2.00B | -32.21M | -1.58% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dynamic Medical Technologies | 1.43B |
| Applied BioCode | 443.69M |
| Diamond Biotechnology | 698.11M |
| OK Biotech | 1.64B |
| A Plus Biotechnology | 825.52M |
| Taiwan Biomaterial | 203.27M |
| Medimaging Integrated Solution | 656.21M |
| Rossmax International | 3.80B |